Violence, DomesticmyPlanKenyaNCT05609786
Dissemination and Implementation of a Web-based Relationship Safety App, myPlanKenya, for Women at Risk for Intimate Partner Violence in Nairobi, Kenya
A study testing Personalized safety planning tool in people with Violence, Domestic and Violence, Sexual, run by Johns Hopkins Bloomberg School of Public Health at 1 site in Kenya.
Trial summary
This effectiveness-implementation hybrid-3 study evaluates dissemination, implementation, and effectiveness of myPlanKenya. myPlanKenya will be disseminated through formal and informal sectors. Read more about this study
- Who is it for?
- Ages 16 years and older, women onlyHealthy volunteers can take part
- Conditions the study is for
- Violence, Domestic, Violence, Sexual, Violence, Gender-Based
- What is being tested?
- Personalized safety planning tool
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 440 participants
- Where
- 1 siteKenya
- Study dates
- 22 Jun 2022to 19 Apr 2025
- Phase
- Interventional
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 16 years and older
- Women only
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- Female
- Age 16 or older
- Physical or sexual partner violence or relationship-based fears within the past six months; behaviorally assessed
- Living in Nairobi, Kenya with no plans to move in the next 12 months
- Access to a safe smart phone or computer (personal or shared), and comfort using it to access the myPlan Kenya app
- Literate in English or Swahili languages; confirmed by reading and completing a short passage by filling in several blanks with the appropriate words, selected from a drop-down menu.
Who cannot join
- Male
- Under age 16
- Have not experienced physical or sexual partner violence or relationship-based fears in past 6 months
- Lives outside of the study area or plans to move within the next 12 months
- Does not have access to a safe smart phone or computer, or is uncomfortable using it to access the myPlan Kenya app
- Illiterate in English or Swahili languages
Trial locations and contacts
1 site in 1 country.
About this study
This effectiveness-implementation hybrid-3 study evaluates dissemination, implementation, and effectiveness of myPlanKenya. myPlanKenya will be disseminated through formal and informal sectors. This clinical trial portion of the study enrolls women at risk for intimate partner violence (IPV) who are referred to myPlanKenya by disseminators (i.e. "end-users").
This trial aims to evaluate the effectiveness of myPlanKenya referral on resilience, health and safety among a cohort of women referred to myPlanKenya based on disclosure of IPV or assessed to have IPV related risks.
- Conditions
- Violence, Domestic, Violence, Sexual, Violence, Gender-Based
- Being tested
- Personalized safety planning tool
- Keywords
- Intimate Partner Violence, Relationships, Safety Planning, technology, implementation
- Medical subject headings
- Coitus
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Personalized safety planning toolBehavioural
The myPlan Kenya app is a web-based safety planning tool that is secure, private, free and personalized to the user. The app includes multiple, evidence-based modules: Strategies (safety strategies tailored to the user's needs and violence experience); Resources (referrals to local health, safety and justice resources and services); About You (questionnaires that help the user assess their relationship safety and tailor their Strategies, including My Relationship, Red Flags, My Safety, My Priorities); Understanding (knowledge sections that share information on relationships and violence, including Healthy Relationships, Harmful Beliefs About Abuse, About Violence).
| Study group | Role | What they receive |
|---|---|---|
| myPlan Kenya | Experimental | myPlan Kenya web-based application Receives: Behavioral: Personalized safety planning tool |
What is being measured
The primary outcome is the main question the study is designed to answer.
Resilience as Assessed by Connor-Davidson Resilience Scale
10-item Connor-Davidson Resilience Scale assesses resilience using a 5-point Likert scale (0-4). Scored from 0-40, with higher scores indicating greater resilience and lower scores indicating lower resilience.
Measured: Baseline, 6-month, 12-month
Decisional Conflict Score
12-item decisional conflict measures (specific to safety), assessed using a 5-point Likert scale (0-4). The mean Decisional Conflict score is multiplied by 25 to create an overall score, ranging from 0-100; 0 (no decisional conflict) to 100 (extremely high decisional conflict).
Measured: Baseline, 6-month, 12-month
Safety/IPV Experience(s) as Assessed by the Conflict Tactics Scale-2
10-item adapted Conflict Tactics Scale-2 (CTS2), which assesses IPV experiences using a 3-point scale on the frequency of these experiences. Score range 0-20; higher score indicates more IPV.
Measured: Baseline, 6-month, 12-month
Percentage of Participants Who Sought Services (Help-seeking)
6-item index on help-seeking, which assesses abuse disclosure and services/information received on a 2-point scale (yes/no); operationally defined as percentage of participants who sought help from any of the services.
Measured: Baseline, 6-month, 12-month
Helpfulness of Services Assessed by Help-Seeking Index
6-item index on help-seeking which assesses abuse disclosure and services/information. Helpfulness of services rated on a 5-point Likert scale (Score range 0-4; with higher score more helpful). Mean helpfulness score of services sought is reported.
Measured: Baseline, 6-month, 12-month
Secondary outcomes (2)
Safety Strategy Score
5-item index on safety strategies used (yes/no), summed for a range of 0-5 with higher scores indicating more safety strategies used. For each strategy used, helpfulness is assessed on a 5-point Likert scale (1-5), with higher scores indicating more helpfulness; mean scores are presented (range 1-5).
Measured: Baseline, 6-month, 12-month
IPV Recognition as Assessed by the Abusive Behaviors Scale
7-item adapted Abusive Behaviors Scale, which assesses IPV recognition using a 5-point Likert scale (0-4). Items are scored from 0-28, with higher scores indicating greater IPV recognition and lower scores indicating lower IPV recognition.
Measured: Baseline, 6-month, 12-month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Nov 2022
- Study start22 Jun 2022
- Primary completion31 Dec 2024
- Study completion19 Apr 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Other trials for Violence, DomesticStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 440 participants (actual)
Sponsor and investigators
- Lead sponsor
- Johns Hopkins Bloomberg School of Public Health
- Sponsor type
- University, hospital or other
- Collaborators
- Ujamaa Africa, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Responsible party
- Sponsor
- Investigators
- Michele Decker, Principal investigator, Johns Hopkins Bloomberg School of Public Health
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05609786
- Sponsor's protocol ID
- IRB00017456
- Other IDs
- R01HD099144
- Acronym
- myPlanKenya
- Status last verified
- Jul 2026
- First submitted
- 2 Nov 2022
- Last updated
- 31 Jul 2026
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 31 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Dissemination and Implementation of a Web-based Relationship Safety App, myPlanKenya, for Women at Risk for Intimate Partner Violence in Nairobi, Kenya
- ClinicalTrials.gov ID
- NCT05609786
- Acronym / sponsor ID
- myPlanKenya / IRB00017456
- Conditions
- Violence, Domestic, Violence, Sexual, Violence, Gender-Based
- Keywords
- Intimate Partner Violence, Relationships, Safety Planning, technology, implementation
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 440 participants (actual)
- Lead sponsor
- Johns Hopkins Bloomberg School of Public HealthUniversity, hospital or other
- Collaborators
- Ujamaa Africa, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Study start
- 22 Jun 2022 (actual)
- Primary completion
- 31 Dec 2024 (actual)
- Study completion
- 19 Apr 2025 (actual)
- First posted
- 8 Nov 2022 (actual)
- Results
- Posted 31 Jul 2026
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This effectiveness-implementation hybrid-3 study evaluates dissemination, implementation, and effectiveness of myPlanKenya. myPlanKenya will be disseminated through formal and informal sectors. This clinical trial portion of the study enrolls women at risk for intimate partner violence (IPV) who are referred to myPlanKenya by disseminators (i.e. "end-users").
This trial aims to evaluate the effectiveness of myPlanKenya referral on resilience, health and safety among a cohort of women referred to myPlanKenya based on disclosure of IPV or assessed to have IPV related risks.
Study design
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| myPlan Kenya | Experimental | Behavioral: Personalized safety planning toolmyPlan Kenya web-based application |
Who may qualify
- Ages
- 16 years and older
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (6 listed)
- Female
- Age 16 or older
- Physical or sexual partner violence or relationship-based fears within the past six months; behaviorally assessed
- Living in Nairobi, Kenya with no plans to move in the next 12 months
- Access to a safe smart phone or computer (personal or shared), and comfort using it to access the myPlan Kenya app
Key exclusion criteria (6 listed)
- Male
- Under age 16
- Have not experienced physical or sexual partner violence or relationship-based fears in past 6 months
- Lives outside of the study area or plans to move within the next 12 months
- Does not have access to a safe smart phone or computer, or is uncomfortable using it to access the myPlan Kenya app
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Personalized safety planning toolThe myPlan Kenya app is a web-based safety planning tool that is secure, private, free and personalized to the user. The app includes multiple, evidence-based modules: Strategies (safety strategies tailored to the user's needs and violence experience); Resources (referrals to local health, safety and justice resources and services); About You (questionnaires that help the user assess their relationship safety and tailor their Strategies, including My Relationship, Red Flags, My Safety, My Priorities); Understanding (knowledge sections that share information on relationships and violence, including Healthy Relationships, Harmful Beliefs About Abuse, About Violence). | Behavioural | myPlan Kenya |
Primary outcome
Resilience as Assessed by Connor-Davidson Resilience Scale
Time frame: Baseline, 6-month, 12-month
10-item Connor-Davidson Resilience Scale assesses resilience using a 5-point Likert scale (0-4). Scored from 0-40, with higher scores indicating greater resilience and lower scores indicating lower resilience.
Decisional Conflict Score
Time frame: Baseline, 6-month, 12-month
12-item decisional conflict measures (specific to safety), assessed using a 5-point Likert scale (0-4). The mean Decisional Conflict score is multiplied by 25 to create an overall score, ranging from 0-100; 0 (no decisional conflict) to 100 (extremely high decisional conflict).
Safety/IPV Experience(s) as Assessed by the Conflict Tactics Scale-2
Time frame: Baseline, 6-month, 12-month
10-item adapted Conflict Tactics Scale-2 (CTS2), which assesses IPV experiences using a 3-point scale on the frequency of these experiences. Score range 0-20; higher score indicates more IPV.
Percentage of Participants Who Sought Services (Help-seeking)
Time frame: Baseline, 6-month, 12-month
6-item index on help-seeking, which assesses abuse disclosure and services/information received on a 2-point scale (yes/no); operationally defined as percentage of participants who sought help from any of the services.
Helpfulness of Services Assessed by Help-Seeking Index
Time frame: Baseline, 6-month, 12-month
6-item index on help-seeking which assesses abuse disclosure and services/information. Helpfulness of services rated on a 5-point Likert scale (Score range 0-4; with higher score more helpful). Mean helpfulness score of services sought is reported.
2 secondary outcomes
Safety Strategy Score
Time frame: Baseline, 6-month, 12-month
IPV Recognition as Assessed by the Abusive Behaviors Scale
Time frame: Baseline, 6-month, 12-month
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 31 Jul 2026.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
Related trials for Violence, Domestic
RecruitingObservational study
Self-Dehumanization and Hesitation to Report Domestic Violence
Domestic Violence
Active, not recruiting
Community Resiliency Collective Efficacy Intervention
Violence, Physical, Violence, Non-accidental
Enrolling by invitation
Evaluation of a Trauma-Informed Partner Violence Intervention Program
Domestic Violence, Post Traumatic Stress Disorder
Not yet recruiting
Metacognitive Interpersonal Therapy for Male Intimate Partner Violence Perpetrators With Personality Disorders
Intimate Partner Violence, Personality Disorders
RecruitingObservational study
Evaluation of the Impact on Mental and Physical Health of Caring for Women Who Are Victims of Sexual and Gender-based Violence, Using a Coordinated Multidisciplinary Approach in Women's Centres or Traditional Health Centres.
Domestic and/or Sexual Violence
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Michele Decker principal investigator
Johns Hopkins Bloomberg School of Public Health
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Personalized safety planning tool in people with Violence, Domestic and Violence, Sexual, run by Johns Hopkins Bloomberg School of Public Health at 1 site in Kenya.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 31 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Kenya. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 31 Jul 2026). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Resilience as Assessed by Connor-Davidson Resilience Scale (time frame: Baseline, 6-month, 12-month). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jul 2026.